based cancer diagnostics space. For example, non-profit outfit Paradigm recently began offering a cancer panel based on DNA and RNA sequencing, as Clinical Sequencing News reported. "As more labs offer somatic alteration panels, this could heighten concerns about Foundation's ability to secure market share and/or main